Name: 摩洛哥进展期帕金森病和设备辅助疗法的适用性：多中心横断面研究
Creator: Taylor & Francis
License: CC BY 4.0

基本信息

模态

表格

大小

0.003616743 GB

许可

CC BY 4.0

创建/更新时间

2025-11-14

版本

v1

资源简介

摩洛哥进展期帕金森病和设备辅助疗法的适用性：多中心横断面研究

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集，收录 3 个文件、合计 3.62 MB，主题涵盖 Advanced Parkinson’s disease、device-aided therapies、deep brain stimulation、levodopa-carbidopa intestinal gel、Morocco，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study》。配套论文《Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study》发表于 Neurodegenerative Disease Management（2025），DOI：10.1080/17582024.2025.2481818。源站首次发布：2025-03-24。

【数据内容】

源站原始描述：This study investigates the prevalence and clinical features of advanced Parkinson’s disease (APD) in Moroccan patients and evaluates their eligibility for Device-Aided Therapies (DATs), including Deep Brain Stimulation (DBS), Continuous Subcutaneous Apomorphine Infusion (CSAI), and Levodopa-Carbidopa Intestinal Gel infusion (LCIG). We conducted a cross-sectional study across 15 facilities in five cities within the Casablanca-Settat region, Morocco. We collected demographics, clinical, and healt…

中文译文（机器翻译，仅供快速理解，请以原文为准）：本研究探讨摩洛哥晚期帕金森病（APD）患者的患病率及临床特征，并评估其接受器械辅助治疗（DATs）的资格，包括脑深部电刺激（DBS）、持续皮下阿扑吗啡输注（CSAI）和左旋多巴-卡比多巴肠凝胶输注（LCIG）。我们在摩洛哥卡萨布兰卡-塞塔特大区的五座城市、15家机构开展了一项横断面研究。我们收集了人口统计学、临床及健康相关生活质量数据。采用逻辑回归分析确定预测疾病进展及DATs资格的因素。本研究纳入370例帕金森病患者，其中44.6%（95%CI：39.5%-49.8%）患有APD。病程每增加一年，APD风险增加8%（ORa = 1.08，p = 0.047）。总体而言，38.9%的患者符合至少一种DAT的条件，其中18.9%符合DBS、35.4%符合CSAI、13.8%符合LCIG；然而，仅1例患者接受了DBS。发病年龄越轻，DATs资格越高，每增加一年，资格降低7%（ORa = 0.93，p = 0.009），而既往有运动参与史使CSAI的几率几乎增至三倍（ORa = 2.87，p = 0.038）。尽管许多摩洛哥患者符合DATs的条件，但其使用率极低。解决可及性障碍对于改善预后至关重要。

【数据结构与技术规格】

文件数 3 个，合计 3.62 MB。esup_1.pdf：application/pdf，184.94 KB。esup_2.pdf：application/pdf，638.89 KB。esup_3.pdf：application/pdf，2.79 MB。数据集 DOI：10.6084/m9.figshare.28652343.v1。

【主题与分类】

源站学科分类：Medicine、Chemical Sciences not elsewhere classified、Biological Sciences not elsewhere classified、Information Systems not elsewhere classified、Science Policy。主题标签：Advanced Parkinson’s disease、device-aided therapies、deep brain stimulation、levodopa-carbidopa intestinal gel、Morocco。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面：https://tandf.figshare.com/articles/dataset/Advanced_Parkinson_s_disease_and_eligibility_for_device-aided_therapies_in_Morocco_a_multicenter_cross-sectional_study/28652343

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study. Taylor & Francis. Daghi, Mohamed; Serhier, Zineb; Lakhdar, Abdelhakim; Otmani, Hicham El

【使用注意】

· 源站最后修改于 2025-11-14，引用时请注意版本时效。

原始链接

https://tandf.figshare.com/articles/dataset/Advanced_Parkinson_s_disease_and_eligibility_for_device-aided_therapies_in_Morocco_a_multicenter_cross-sectional_study/28652343

访问原始数据

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付，我们提供全链路闭环服务，让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持？联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务（收技术服务费，非数据销售）

暂未开放

当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取（Figshare）

源站标题：Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study
DOI：10.6084/m9.figshare.28652343.v1
发布日期：2025-03-24
文件数：3 个
文件总体积：3.62 MB
源站页面：https://tandf.figshare.com/articles/dataset/Advanced_Parkinson_s_disease_and_eligibility_for_device-aided_therapies_in_Morocco_a_multicenter_cross-sectional_study/28652343

命令行下载

curl -L -o "esup_1.pdf" "https://ndownloader.figshare.com/files/53185365"
curl -L -o "esup_2.pdf" "https://ndownloader.figshare.com/files/53185368"
curl -L -o "esup_3.pdf" "https://ndownloader.figshare.com/files/53185371"

文件清单

esup_1.pdf（184.94 KB）
esup_2.pdf（638.89 KB）
esup_3.pdf（2.79 MB）

文件总体积 3.62 MB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

This study investigates the prevalence and clinical features of advanced Parkinson’s disease (APD) in Moroccan patients and evaluates their eligibility for Device-Aided Therapies (DATs), including Deep Brain Stimulation (DBS), Continuous Subcutaneous Apomorphine Infusion (CSAI), and Levodopa-Carbidopa Intestinal Gel infusion (LCIG).
We conducted a cross-sectional study across 15 facilities in five cities within the Casablanca-Settat region, Morocco. We collected demographics, clinical, and health-related quality of life data. Logistic regression identified factors predicting disease progression and DATs eligibility.
This study included 370 patients with Parkinson’s disease, of whom 44.6% (95%CI: 39.5%-49.8%) had APD. Each additional year of disease duration increased APD odds by 8% (ORa = 1.08, p = 0.047). Overall, 38.9% of patients qualified for at least one DAT, including 18.9% for DBS, 35.4% for CSAI, and 13.8% for LCIG; however, only one patient received DBS. Younger age at onset was associated with greater DATs eligibility, with each additional year reducing eligibility by 7% (ORa = 0.93, p p = 0.009), while prior sports engagement nearly tripled the odds for CSAI (ORa = 2.87, p = 0.038).
Although many Moroccan patients qualify for DATs, their use is minimal. Addressing access barriers is crucial to improve outcomes.